Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal neostigmine vs sufentanil vs magnesium sulfate with bupivacaine for postoperative pain after TURP
IRCT20260509069314N1Phase 2Recruiting
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Neostigmine + bupivacaine, Sufentanil + bupivacaine and Magnesium sulfate + bupivacaine (3 arms). Primary endpoints: Pain, Shivering and 6 more. Started May 2026; status: recruiting.
02
Drugs
neostigminesufentanilmagnesium sulfatebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20260509069314N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260509069314N1.